Correction to: Glycolytic inhibitors 2-deoxyglucose and 3-bromopyruvate synergize with photodynamic therapy respectively to inhibit cell migration (Journal of Bioenergetics and Biomembranes, (2015), 47, 3, (189-197), 10.1007/s10863-015-9604-1);Glycolytic inhibitors 2-deoxyglucose and 3-bromopyruvate synergize with photodynamic therapy respectively to inhibit cell migration

Journal of Bioenergetics and Biomembranes

Volumn 47, Issue 3, 2015, Pages 189-197

  Feng, Xiaolan ^a   Wang, Pan ^a   Liu, Quanhong ^a   Zhang, Ting ^a   Mai, Bingjie ^a   Wang, Xiaobing ^a  

^a SHAANXI NORMAL UNIVERSITY   (China)

Author keywords

2 deoxyglucose; 3 bromopyruvate; Cell migration; MDA MB 231 cells; Photodynamic therapy

Indexed keywords

BROMOPYRUVATE; DEOXYGLUCOSE; PYRUVIC ACID DERIVATIVE; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE;

CELL ADHESION; CELL MOTION; CELL SURVIVAL; DRUG EFFECTS; DRUG POTENTIATION; FLUORESCENT ANTIBODY TECHNIQUE; GLYCOLYSIS; HUMAN; PHOTOCHEMOTHERAPY; PROCEDURES; SCANNING ELECTRON MICROSCOPY; TRIPLE NEGATIVE BREAST NEOPLASMS; TUMOR CELL LINE;

CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; DEOXYGLUCOSE; DRUG SYNERGISM; FLUORESCENT ANTIBODY TECHNIQUE; GLYCOLYSIS; HUMANS; MICROSCOPY, ELECTRON, SCANNING; PHOTOCHEMOTHERAPY; PYRUVATES; TETRAZOLIUM SALTS; THIAZOLES; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 84939956353     PISSN: 0145479X     EISSN: 15736881     Source Type: Journal    
DOI: 10.1007/s10863-022-09955-2     Document Type: Erratum

References (49)

1. Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO et al (2011) Photodynamic therapy of cancer: an update. CA Cancer J Clin 61:250–281
2. Buzoglu HD, Unal H, Ulger C, Mert S, Kücükyildirim S, Er N (2009) The zymographic evaluation of gelatinase (MMP-2 and −9) levels in acute and chronic periapical abscesses. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 108:e121–e126
3. Chambers AF, Groom AC, MacDonald IC (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2:563–72
4. Chin WW, Lau WK, Heng PW, Bhuvaneswari R, Olivo M (2006) Fluorescence imaging and phototoxicity effects of new formulation of chlorin e6-polyvinylpyrrolidone. J Photochem Photobiol Biol 84:103–110
5. Conor C, Lynch Lynn M (2002) Matrisian matrix metalloproteinases in tumor–host cell communication. Differ 70:561–573
6. Cooper JA (1991) The role of actin polymerization in cell motility. Annu Rev Physiol 53:585–605
7. Correia I, Chu D, Chou YH, Goldman RD, Matsudaira P (1999) Integrating the actin and vimentin cytoskeletons: adhesion-dependent formation of fimbrin–vimentin complexes in macrophages. J Cell Biol 146:831–42
8. Dahle J, Angell-Petersen E, Steen HB, Moan J (2001) Bystander effects in cell death induced by photodynamic treatment UVA radiation and inhibitors of ATP synthesis. Photochem Photobiol l73:378–387
9. Davids LM, Kleemann B (2011) Combating melanoma: the use of photodynamic therapy as a novel, adjuvant therapeutic tool. Cancer Treat Rev 37:465–475
10. Dominguez R, Holmes KC (2011) Actin structure and function. Annu Rev Biophys 40:169–86
11. Feng XL, Zhang Y, Wang P, Liu QH, Wang XB (2014) Energy metabolism targeted drugs synergize with photodynamic therapy to potentiate breast cancer cell death. Photochem Photobiol Sci 13(12):1793–803
12. Firczuk M, Winiarska M, Szokalska A, Jodlowska M, Swiech M, Bojarczuk K et al (2011) Approaches to improve photodynamic therapy of cancer. Front Biosci 16:208–224
13. Foda HD, Zucker S (2001) Matrix metalloproteinases in cancer invasion, metastasis and angiogenesis. Drug Discov Today 478–482
14. Foultier MT, Vonarx-Coinsmann V, Cordel S, Combre A, Patrice T (1994) Modulation of colonic cancer adhesiveness by haematoporphyrin derivative therapy. J Photochem Photobiol B Biol 23:9–17
15. Friedl P, Alexander S (2011) Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 147:992–1009
16. Gatenby RA, Gawlinski ET (2003) The glycolytic phenotype in carcinogenesis and tumor invasion: insights through mathematical models. Cancer Res 63:3847–54
17. Golding JP, Wardhaugh T, Patrick L, Turner M, Phillips JB, Bruce JI et al (2013) Targeting tumour energy metabolism potentiates the cytotoxicity of 5-aminolevulinic acid photodynamic therapy. British Journal of Cancer 1–7
18. Gomer CJ, Ferrario A, Murphree AL (1987) The effect of localized porphyrin photodynamic therapy on the induction of tumour metastasis. Br J Cancer 56(1):27–32
19. Gupta S, Farooque A, Adhikari JS, Singh S, Dwarakanath BS (2009) Enhancement of radiation and chemotherapeutic drug responses by 2-deoxy-D-glucose in animal tumors. J Cancer Res Ther 5(Suppl 1):S16–20
20. Hammoudi N, Ahmed KB, Garcia-Prieto C, Huang P (2011) The Warburg effect and its cancer therapeutic implications. Chin J Cancer 30:508–525
21. Juarranz A, Jaén P, Sanz-Rodríguez F, Cuevas J, González S (2008) Photodynamic therapy of cancer. Basic principles and applications. Clin Transl Oncol 10:148–154
22. Khaitlina S (2001) Functional specificity of actin isoforms. Int Rev Cytol 202:35–98
23. Kirveliene V, Sadauskaite A, Kadziauskas J, Sasnauskiene S, Juodka B (2003) Correlation of death modes of photosensitized cells with intracellular ATP concentration. FEBS Lett 553:167–172
24. Kochubeev GA, Frolov AA, Kostiuk VA, Pronskaia IV, Gurinovich GP (1988) Photodynamic effect of chlorine e6 on erythrocyte membranes. Biofizika 33:471–474
25. Lardner A (2001) The effects of extracellular pH on immune function. J Leukoc Biol 69:522–30
26. Li H, Zhang K, Liu LH, Ouyang Y, Bu J, Guo HB et al (2014) A systematic review of matrix metalloproteinase 9 as a biomarker of survival in patients with osteosarcoma. Tumor Biol 35(6):5487–91
27. Majumder M, Tutunea-Fatan E, Xin X, Rodriguez-Torres M, Torres-Garcia J, Wiebe R et al (2012) Co-expression of α9β1 integrin and VEGF-D confers lymphatic metastatic ability to a human breast cancer cell line MDA-MB-468LN. PLoS One 7(4):e35094
28. Margaron P, Sorrenti R, Levy JG (1997) Photodynamic therapy inhibits cell adhesion without altering integrin expression. Biochim Biophys Acta 1359(3):200–10
29. Maschek G, Savaraj N, Priebe W, Braunschweiger P, Hamilton K, Tidmarsh GF et al (2004) 2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo. Cancer Res 64:31–4
30. McInroy L, Määttä A (2007) Down-regulation of vimentin expression inhibits carcinoma cell migration and adhesion. Biochem Biophys Res Commun 360:109–14
31. Mojzisova H, Bonneau S, Vever-Bizet C, Brault D (2007) Cellular uptake and subcellular distribution of chlorin e6 as functions of pH and interactions with membranes and lipoproteins. Biochim Biophys Acta 1768:2748–2756
32. Murphy G, Nagase H (2008) Progress in matrix metalloproteinase research. Mol Aspects Med 29:290–308
33. Noodt BB, Rodal GH, Wainwright M, Peng Q, Horobin R, Nesland JM et al (1998) Apoptosis induction by different pathways with methylene blue derivative and light from mitochondrial sites in V79 cells. Int J Cancer 75:941–948
34. Pelicano H, Martin DS, Xu RH, Huang P (2006) Glycolysis inhibition for anticancer treatment. Oncogene 25:4633–4646
35. Peter LP (2007) Warburg, me and hexokinase 2: multiple discoveries of key molecular events underlying one of cancers’ most common phenotypes, the “warburg effect”, i.e., elevated glycolysis in the presence of oxygen. J Bioenerg Biomembr 39:211–222
36. Radestock A, Elsner P, Gitter B, Hipler UC (2007) Induction of apoptosis in HaCaT cells by photodynamic therapy with chlorin e6 or pheophorbide α. Skin Pharmacol Physiol 20:3–9
37. Rousset N, Vonarx V, Eléouet S, Carré J, Kerninon E, Lajat Y et al (1999) Effects of photodynamic therapy on adhesion molecules and metastasis. J Photochem Photobiol B 52(1–3):65–73
38. Schoenenberger CA, Mannherz HG, Jockusch BM (2011) Actin: from structural plasticity to functional diversity. Eur J Cell Biol 90:797–804
39. Shapiro SD (1998) Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr Opin Cell Biol 10(5):602–8
40. Shevchuk I, Chekulayev V, Moan J, Berg K (1996) Effects of the inhibitors of energy metabolism, lonidamine and levamisole on 5-aminolevulinic-acidinduced photochemotherapy. Int J Cancer 67:791–799
41. Tallant C, Marrero A, Gomis-Rüth FX (2010) Matrix metalloproteinases: fold and function of their catalytic domains. Biochim Biophys Acta 1803:20–28
42. Uzdensky AB, Juzeniene A, Kolpakova E, Hjortland GO, Juzenas P, Moan J (2004) Photosensitization with protoporphyrin IX inhibits attachment of cancer cells to a substratum. Biochem Biophys Res Commun 322(2):452–7
43. Uzdensky A, Kolpakova E, Juzeniene A, Juzenas P, Moan J (2005) The effect of sub-lethal ALA-PDT on the cytoskeleton and adhesion of cultured human cancer cells. Biochim Biophys Acta 1722(1):43–50
44. Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324:1029–1033
45. Vonarx V, Foultier MT, Xavier de Brito L, Anasagasti L, Morlet L, Patrice T (1995) Photodynamic therapy decreases cancer colonic cell adhesiveness and metastatic potential. Res Exp Med (Berl) 195(2):101–116
46. Ward PS, Thompson CB (2012) Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell 21:297–308
47. Weiss L, Ward PM (1983) Cell detachment and metastasis. Cancer Metastasis Rev 2:111–127
48. Xiao H, Li S, Zhang D, Liu T, Yu M, Wang F (2012) Separate and concurrent use of 2-deoxy-D-glucose and 3-bromopyruvate in pancreatic cancer cells. Oncol Rep 29(1):329–34
49. Zimcík P, Miletín M (2004) Photodynamic therapy as a new prospective method for cancer treatment. I. History, basic principles. Ceska Slov Farm 53:219–224